Neurocrine Biosciences, Inc.
NBIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $340 | $264 | $194 | $233 |
| Short-Term Investments | $775 | $712 | $749 | $843 |
| Receivables | $728 | $596 | $516 | $479 |
| Inventory | $69 | $57 | $59 | $57 |
| Other Curr. Assets | $246 | $121 | $119 | $112 |
| Total Curr. Assets | $2,158 | $1,749 | $1,638 | $1,725 |
| Property Plant & Equip (Net) | $566 | $584 | $589 | $592 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $36 | $37 | $36 | $37 |
| Long-Term Investments | $118 | $961 | $910 | $864 |
| Tax Assets | $369 | $537 | $499 | $486 |
| Other NC Assets | $1,019 | $22 | $15 | $16 |
| Total NC Assets | $2,107 | $2,141 | $2,050 | $1,994 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,266 | $3,890 | $3,688 | $3,719 |
| Liabilities | – | – | – | – |
| Payables | $120 | $105 | $110 | $110 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $26 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $518 | $416 | $413 | $398 |
| Total Curr. Liab. | $638 | $546 | $523 | $508 |
| LT Debt | $428 | $439 | $448 | $455 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $196 | $210 | $182 | $166 |
| Total NC Liab. | $624 | $649 | $629 | $621 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $439 | $448 | $455 |
| Total Liabilities | $1,262 | $1,196 | $1,152 | $1,129 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $294 | $85 | -$5 | $29 |
| AOCI | $13 | $13 | $9 | $6 |
| Other Equity | $2,696 | $2,597 | $2,532 | $2,555 |
| Total Equity | $3,004 | $2,694 | $2,536 | $2,590 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,266 | $3,890 | $3,688 | $3,719 |
| Net Debt | $88 | $175 | $253 | $222 |